Biological Activity
TAS-120 is a novel, potent and highly selective FGFR inhibitor, used for antitumor treatment.
In Vitro
No in vitro data are provided in the current product source. Contact us for further information.
In Vivo
TAS-120 (3, 30, 100 mg/kg/day, p.o.) exerts an anti-tumor effect in mice. TAS-120 shows anti-tumor effect by administering at moderate intervals, such as intermittent administration of every other day dosing and 2 times/week, and reducing the sustained elevation and weight suppression blood phosphorus level, and take a antitumor effective as daily administration[1].
References & source
Published experimental findings depend on the model and assay conditions. They do not guarantee equivalent performance in every application. For laboratory research use only.